We are pleased to announce the release of the new Transplant Evidence App for Android and iPhone. The app delivers the monthly Transplant Trial Watch direct to your phone, with push notifications, review videos, and the ability to share interesting studies with your colleagues and friends. You can also search the archives, filtering by organ […]
The May 2018 edition of the Transplant Trial Watch is now available online. This month’s studies include the impact of allograft nephrectomy on subsequent transplants, the mid- and long-term risks of living kidney donation, and the use of transcatheter arterial embolisation in patients with APKD prior to transplant.
The April 2018 Transplant Trial Watch is now available. This month’s studies include a trial of Eculizumab for prevention of ischaemia-reperfusion injury, a systematic review of liver transplantation for alcoholic hepatitis, and a review of the impact of positive preservation fluid cultures.
The March 2018 Transplant Trial watch is now available online and via the CET app. This month’s papers include an evaluation of inclusion/exclusion criteria in transplant clinical trials, self-monitoring of kidney function after transplantation and extended versus modified right lobe grafts for live donor liver transplantation.
The December 2017 edition of the Transplant Trial Watch is now available online. This month’s studies include PDT vs. Imiquimod for the treatment of actinic keratoses in transplant recipients, omitting affective attitude questions to improve intention to become an organ donor, and a meta-analysis of ECMO vs. bypass during lung transplantation.
The November 2017 Transplant Trial Watch is now available. This month’s papers include a non-inferiority study of low-dose sirolimus combined with tacrolimus in renal tranpslant recipients, a meta-anlysis of remote ischaemic conditioning protocols, and propofol to reduce hepatic ischaemia reperfusion injury.
The October 2017 edition of the Transplant Trial Watch is now available. This month’s studies include long term results from the original phase II Belatacept study, a Cochrane review of monoclonal and polyclonal antibodies for renal transplant recipients, and a systematic review of in-situ perfusion techniques in liver transplantation.
The September 2017 edition of the Transplant Trial Watch is now online. This month’s studies include paracalcitol in renal transplant recipients, a new formula for estimation of standard liver volume, and protective mechanical lung ventilation in lung transplantation.